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The usefulness of data from various sources for a cancer risk estimation of urban air pollution is discussed. Considering the irreversibility of initia-
tions, a multiplicative model is preferred for solid tumors. As has been concluded for exposure to ionizing radiation, the multiplicative model, in com-
parison with the additive model, predicts a relatively larger number of cases at high ages, with enhanced underestimation of risks by short follow-up
times in disease-epidemiological studies. For related reasons, the extrapolation of risk from animal tests on the basis of daily absorbed dose per kilo-
gram body weight or per square meter surface area without considering differences in life span may lead to an underestimation, and agreements
with epidemiologically determined values may be fortuitous. Considering these possibilities, the most likely lifetime risks of cancer death at the aver-
age exposure levels in Sweden were estimated for certain pollution fractions or indicator compounds in urban air. The risks amount to approximately
50 deaths per 100,000 for inhaled particulate organic material (POM), with a contribution from ingested POM about three times larger, and alkenes,
and butadiene cause 20 deaths, respectively, per 100,000 individuals. Also, benzene and formaldehyde are expected to be associated with consider-
able risk increments. Comparative potency methods were applied for POM and alkenes. Due to incompleteness of the list of compounds consid-
ered and the uncertainties of the above estimates, the total risk calculation from urban air has not been attempted here. - Environ Health Perspect
102(Suppl 4):173-181 (1994).
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Introduction
The main purpose of this paper is the esti-
mation of cancer risks from urban air pollu-
tants on the basis ofdata from carcinogenici-
ty tests with laboratory animals. This paper
serves as a parallel of the estimations based
on epidemiological data presented by
Hemminki and Pershagen (1). Both papers
use the population-weighted exposure data
for Sweden (Table 1), presented by Bostrom
et al. (2).
Since any meaningful effort to arrive at
reliable cancer risk estimates requires a mul-
tiprong approach (3-5), it is necessary to
refer to complementary information from
sources other than the long-term animal
tests. For instance, epidemiological data
may serve to check the reasonableness of
risks estimated by extrapolation from ani-
mal carcinogenicity tests, even if they are
unable to show a significant effect (3-5).
This paper may be seen as a discussion of
the usefulness for risk estimation of infor-
mation from different sources.
Multiplicative versus
Additive Models
In similarity with cancer risks from ioniz-
ing radiations, risks of chemically induced
cancers have been expressed as a relation-
ship between exposure dose or absorbed
dose and individual risk (the probability of
acquiring cancer) or collective risk (the
expected number of cases in an exposed
population) (6,7). Continued and extend-
ed follow-up of exposed populations, par-
ticularly atomic bomb survivors in
Hiroshima and Nagasaki and groups with
medical radiation treatment, revealed that
radiation-induced incremental incidences
are approximately proportional to back-
ground incidences:
P(D) = (1 + D) XP [1]
where [B is the risk coefficient for the linear
dependence on the dose (D) assumed to pre-
vail at low doses and P0 is the background
incidence. Earlier it was assumed that the
riskhas adose-related absolutevalue:
P(D) = P° + kD [2]
where kis the risk coefficient.
To the extent that initiations are irre-
versible, a multiplicative increase of cancer
incidence would be expected to result from
exposure to initiators in general. The validi-
ty ofa multiplicative model for chemicals is
supported by the outcome of an evaluation
ofdata from carcinogenicity tests ofethylene
oxide (8). This model also has been applied
to diesel exhausts (9,10) in the past. [It
should be stressed that a linear multiplicative
model is expected to hold at doses so low
that the reversible cocarcinogenic and pro-
motive effects do notoccur (11).]
The validity of the multiplicative model
agrees with results of experimental studies
of radiogenic cancer where an additive
model could be rejected in most cases in
favor ofthe multiplicative model (12). For
This paper was presented at the Symposium on Risk
Assessment of Urban Air: Emissions, Exposure, Risk
Identification and Risk Quantitation held 31 May-3
June, 1992, in Stockholm, Sweden.
This work was supported by the Swedish
Environmental Protection Agency, Svenska Shell AB,
and the U.S. Department of Energy (Project No. DE-
FG02-89ER60784).
Address correspondence to Margareta T6rnqvist,
Department of Radiobiology, Stockholm University, S-
106 91 Stockholm, Sweden. Telephone 46 8 164059.
Fax 46 8 166488.
Table 1. Average exposure to several airborne genotoxic substances in Sweden (2)and unit lifetime riskfactors (15).
Substance Mean annual exposure perm3 Unit risk factor perpg/m3
Polycyclic aromatic hydrocarbons 19.0 ng 1 x 10-1 (as B[a]P)
Benzo[a]pyrene 0.7 ng
Benzene 3.7 pg 8 x1cV5
Formaldehyde 1.2 pg 1 x10 5
Acetaldehyde 1.0 pg 2 x 10-
Ethene 1.8 pg 1 x i-4(ethylene oxide)
Propene 2.3 pg
Butadiene 0.7 pg 3x10-4
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these reasons, the National Research Council
(13) has adopted the multiplicative model.
The United Nations Scientific Committee
on the Effects of Atomic Radiation
(UNSCEAR) compares the two models
(14). In this respect the leukemias present
an exception. Probably due to depletion of
the stem cells that existed at the time of
radiation exposure, the raised incidence
ceases after approximately 30 years. The
shift to the multiplicative model led to a
large number of cancer cases because an
exposure earlier in life is expected to occur
at those higher ages, around and above 65
years, where the background incidence
undergoes a rapid rise. This also means
that the total number of cases per unit of
radiation dose will be some 4 times higher
than was expected from the additive model.
A small part ofthis increase is due to reeva-
lutation of the atomic bomb radiation
doses in Hiroshima and Nagasaki (13,14).
One consequence of the adoption of a
multiplicative risk model will be that a con-
siderable part ofthe risk, or number ofcases
in a population, is expected to occur towards
the end of the life and will become a ques-
tion of the manner of death rather than of
years lost. In the past we have calculated
risks from defined exposure doses in terms of
probability per year, or number ofcases per
year, while considering a steady-state condi-
tion established if the exposure continues
through decades. Due to the skew distribu-
tion ofrisk over ages, this way ofexpressing
the risk may be misleading. Since exposure
levels change fast-hopefully to the better-
within times which are short in comparison
to a human life span (70 years), it is impor-
tant to stress that the risk from one year's
exposure means the (average) probability,
due to this exposure, of acquiring cancer at
some time later in life. The annual risks cal-
culated below from the unit lifetime risk
coefficients of the EPA (Table 1) (15) for
the risk from life-long exposure to 1 pg/mi3
should be seen in this sense.
Methodsfor Risk Estimation
Epidemiology
Disease-epidemiological studies have a major
drawback in their insensitivity (low power).
A considerable increase of the incidence or
death rate is required to show, with statistical
significance, that there is an effect and an
even higher increase is necessary to estimate
the magnitude ofthe effect. Therefore, epi-
demiological studies are applied best in situa-
tions with a considerably raised exposure, as
in work environments. The risks at lower
exposure levels then can be estimated by
extrapolation. Other problems encountered
are the long latency times, several years (for
leukemias) to several decades, difficulties of
reconstructing reliable exposure data, and the
occurrence ofconfounding factors (e.g., dif-
ferences in smoking habits and other life-
style factors between exposed and control
groups). Because ofsuch difficulties, disease-
epidemiological methods are oflimited use-
fulness in risk assessment, particularly with
regard to quantitative aspects.
The measurement ofbiological and chemi-
cal biomarkers permits a considerable increase
ofthe sensitivity ofepidemiological investiga-
tions, provided the relationship between
observed biomarker level and risk can be
established. The disadvantage oflong latency
can also be eliminated. Furthermore, the
measurement of adducts from carcinogens
(i.e. products ofreactionwith cellular macro-
molecules), a method that is several orders of
magnitude more sensitive than disease-epi-
demiological investigations, permits identifi-
cation ofcausative factors and thus avoids the
influence ofconfounding processes ofother
factors.
Animal Carinogenicity
Animal carcinogenicity tests are informative
where human data are not available and are
advantageous because administered doses are
well defined and no confounding factors
need to be considered in comparisons with
control groups. However, problems are
encountered, in the translation of observed
excess incidences to human risks at low
exposure levels. In this translation, two
extrapolations are involved from animal
species to man and from the usually high
experimental doses (and dose rates) to the
low ones in human target populations.
Animal carcinogenicity tests have the fol-
lowing problems. a) The high dose and
dose rates that have to be applied in order to
obtain decisive data from animal groups of
limited size lead to side effects that could be
described as cocarcinogenic or promotive,
with consequential nonlinear dose-response
relationships. Although this is accounted
for to some extent byestimating the slope of
the linear low-dose component ofa multihit
model (16), the reliability ofthe procedure
should not be taken for granted. b)
Interspecies differences in metabolism have
been corrected for by scaling ofthe dose in
mg/kg body weight to mg/m2 body surface
area, which decreases the overall metabolic
rate with increasing body size (16). This
procedure appears to be an administratively
useful rule ofthumb rather than an effort to
find the true risk. c) The question whether
the life-time dose or the dose per day (i.e., a
dose rate) determines the risk creates an
uncertainty by a factor 35 corresponding to
the human-to-rodent longevity ratio (17).
Due to the irreversibility of genotoxic
events, the lifetime dose is expected to have
a decisive influence, as has been found for
ionizing radiation (12) and recently for
alkylating chemotherapeutics (18).
Therefore, the extrapolation on the basis of
daily dose, as done by the U.S. EPA (16),
may lead to considerable underestimation.
Partly, this underestimation is counteracted
by scaling to the dose per unit body area,
which renders humans about six times
more sensitive than rats and about 13 times
more than mice. Agreements found
between risks estimated in this way from
animal data and incidences observed in epi-
demiological studies (19) may be referred
to as an underestimation ofthe latter in sev-
eral cases due to follow-up times that were
too short (20).
For instance, in the case of ethylene
oxide, the human data are predominated
by leukemias (i.e., the malignancies that
appear with the shortest latency times)
(21). The cohorts with exposure to ethyl-
ene oxide thus show a resemblance to the
atomic bomb survivors in Hiroshima and
Nagasaki who exhibited mainly leukemias
in approximately the first 15 years (7,8).
Due to the distribution of the dose to all
tissues, ethylene oxide is expected to
increase the incidence of solid tumors,
which corresponds with observations in
rats and mice in which ethylene oxide has
been shown to raise the incidence of
tumors of most types that occur normally
in the animal strain (8). For carcinogens
acting as promoters or cocarcinogens in
nonlinear dose dependence, the situation
will be more complicated mainly because
the animal tests do not mimic the human
situation with variable dose rate (concen-
tration). It seems that determination of
target doses in exposed humans and in lab-
oratory organisms is a necessary step to
solve these problems.
Comparative PotencyMethods for
RiskEstimation
If the risk coefficients (3 or ki in
Equations 1 and 2) for aparticular exposure
i are unknown, these coefficients could be
evaluated, at least in principle, through
their relative potency in comparison with
an agent j with known risk coefficients
or kj, respectively. Ifwe denote the relative
potencyby Qij
Pi ki Qij =kj "Pi k. [3]
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Table 2. Afew components of automotive engine exhausts, emitted per km (29).
Gasoline exhausts Diesel exhausts
Withoutcatalyst With catalyst Light Heavy
Gas phase
Benzene mg 100 8 15 ND
Formaldehyde mg 35 2.5 12 ND
Fluoranthene pg 280 4.4 186 770
Particle phase
Particles mg 62 110 245 1030
Benzo[a]pyrene pg 12 0.25 8 34
Fluoranthene pg 211 3.1 139 580
1-Nitropyrene pg 0.2 <0.1 6.8 28
(B[a]P per mg particles) (0.2) (0.02) (0.03) (0.04)
Ratio offluoranthene
(total)/B[a]P 40 30 40 40
ND, no data.
the risks according to Equations 1 and 2
could be estimated through
P(D) = (1 + Qijxj xDj)P° [4]
or
P(D) = P°+ Qij x k x Di [5]
for the relative and absolute risks, respective-
ly. The values of Qi are determined by rel-
evant bioassays. The approach is based on
the assumption that the values ofQ .. are the
same in the bioassay systems and in humans.
Evidently the method is applicable at expo-
sure levels that are low enough to make the
dose-response relationships seem linear.
Two approaches have been forwarded to
estimate cancer risks by comparative potency
methods. Lewtas et al. (22,23) applied the
principle for risk estimation of particulate
organic matter (POM) from automotive
engine exhausts and from other combustion
processes, using the epidemiologically estab-
lished coefficients for lung cancer risk in coke
oven topsideworkas reference standard. The
bioassay systems they used comprised a data
base ofseveral tests including tumor initiation
by painting mouse skin with the methylene
chloride (CH2C12) extracts to be compared.
The method was validated by agreement
between estimated and epidemiologically
determined lung cancer risks from roofing tar
emissions and tobacco smoking (23).
The Stockholm approach (20,24-26),
often referred to as the rad-equivalence
approach, initially was directed towards risk
estimation of specific chemicals with low
linear energy transfer (LET) radiation as
reference standard. In this prospective risk
model, the value of Qi is based on the tar-
get doses of the chemicals (i) determined
by hemoglobin and/or DNA adducts and
doses of y radiation (j), prompting the
same response.
Risk Estimation
PAH, POM, and Particles
The population-weighted average concentra-
tion of polycyclic aromatic hydrocarbons
(PAH) in Sweden is given as 0.7 ng/m3
benzo[a]pyrene (B[a]P) (Table 1). With the
EPA unit risk factor for lung cancer death
from PAH this would correspond to an aver-
age risk of 7 x 10-5 from life-long expo-
sure or eight cases ofdisease per year in the
Swedish population of8.4 million.
Under the Swedish Urban Air Project,
PAH in the particulate fraction was estimat-
ed to cause approximately 65 cancer cases
annually in Sweden (27). The estimate
was based on a preliminary determination
of the rad-equivalence of B[a]P in the
mouse (7 rad-equivalence [mg/kg bw] -1)
(28) and an estimate ofthe average contri-
bution ofB[a]P (approximately 2%) to the
response to total particle extracts (unpub-
lished data). Judging the average level of
B[a]P to be 0.5 ng/m and inhalation to be
20 m3/day, the cancer risk from B[a]P was
estimated at 1.3 cases/year and the risk
from £PAH to 50 x 1.3 = 65 cases/year
(27). For the 0.7 ng/m3 now presented as
a probable average level (Table 1), the cor-
responding number due to XPAH would
be 90 cases annually in Sweden, corre-
sponding to a lifetime risk of 80 x 10-
Since this value is not restricted to lung
cancer but encompasses the total cancer
incidence, the two figures are compatible.
This does not mean, however, that the esti-
mates are correct, even to the order of mag-
nitude. The use ofthe unit risk coefficient
for one component, B[a]P, is no doubt an
oversimplification because many factors
influencing risk are disregarded. These cir-
cumstances will be discussed briefly in the
following section.
Relevance ofBenzo[a]pyrene
as PAH Indicator
Apart from the instability of B[a]P, several
objections have been raised against the use of
this compound as an indicator ofthe geno-
toxicity ofPAH in air pollution. Part ofthe
PAH is bound to particles, and PAH with 3
to 4 rings that are present largely in the gas
phase are not included when the PAH analy-
sis is carried out on extractable organic mat-
ter. Certain volatile or semivolatile PAH
(e.g., methylphenanthrenes and fluoran-
thene) occur at relatively high concentrations
(Table 2) and are effective mutagens (30). It
has also been pointed out that although
B[a]P may be a useful indicator of the car-
cinogenic potential of the PAH-rich coke
oven emissions and similar emissions, its use
for diesel-engine exhausts and tobacco smoke
would represent only the PAH component
of these emissions, which contain a broader
range of carcinogenic components (31).
Pott and Heinrich (32) have demonstrated
by a compilation of epidemiological and
experimental data that at equal lung cancer
incidence provoked by fumes from heated
pitch (as a model for coke oven emission),
tobacco smoke, and diesel exhausts, the rela-
tive intakes of B[a]P are 1, approximately
0.01 and approximately 0.001, respectively.
It may appear that these differences are
allowed for in the risk assessments ofLewtas
(23) by the comparative potency method
(seeabovel. Expressing the lung cancer risk
per pg/m of extractable organic material
from diesel and gasoline exhaust particles,
respectivel, she arrives at risk coefficients of
2.3 x 10 and 1.2 x 10-4 with a weighted
mean ofabout 2 x 10-. With an assumed
average particle level of 5 pg/mi3 in Sweden
(Table 3), of which about 7% (33) is
extractable, the associated riskwould be
5(pg/m3)x
7 x[2x10 4(pg/m3)-l 100
=7x 10-5 [6]
Considering the rough approximations
made, the value is compatible with the one
based directly on the B[a]P content. This
agreement may be fortuitous.
Table 3. Particle levels in polluted air in Sweden. a
Diesel particles, Soot
pg/i3 pg/mi
Average in the country 1.0 3.7
Loaded city areas 1-2 8-10
High-traffic areas 2-4
a C-E. Bostrom, personal communication.
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Table 4. Estimated cancer risks from components in urban air pollution.
Unit risk estimate
Individual lifetime risk
of cancer death, x 105
Particle phase
PAH, POM (as B[a]P)
Unit risk, lung cancer
Diesel particles, lung cancer (41)
Other particles
Rad-equivalence, all cancer
(diesel epidemiology, lung cancer)
PAH uptake via food chain
Gas phase
PAH
Ethene, all cancer
rad-equivalence, all cancer
Propene
Butadiene
Benzene, leukemia
All cancer
Other alkenes
Formaldehyde, nasal
All cancer
Acetaldehyde
Othercarbonyls
7
7
Adopted estimate
Individual lifetime risk Cases
ofcancer death, a X 105 year
50
(80)
(-100?)
1.4
21
3
13
2.1
21
1.2
0.2
ofcircumstances, however, renderthe numer-
ical value ofthe estimated riskvery uncertain.
ofdisease per Too little is known about the mechanism of
in Sweden a action to permit the prediction of a linear
component in the dose-response curve; lin-
100 earity in the low-dose region would be
expected ifsingle particles induce the produc-
tion offree radicals that interact with DNA
in target cells. It is indicated by the consider-
able sizeofthelungs afterprolonged exposure
(43,44) and the increased number of neu-
-300 trophils in bronchoalveolar lavage fluid (40)
;, that the particle burden provokes an inflam-
mation that might act as a cancer promoter.
30 Since the dose-response relationship of a
5 nongenotoxic promoter action may have a
-50 no-effect threshold (11), the possibility that
-5 the risk is close to zero is notexcluded. as also %4.,-.so AOKI .0 t-. s-w ..W I %,-, sw -
10 pointed out by Pott as well (41). It is also
expected that the gaseous components to
25 which the animals were simultaneously
<1
Abbreviations: B[a]P, benzo[alpyrene; PAH, polycyclic aromatic hydrocarbons; POM, polycyclic organic matter.
a Considering theoretical and statistical errors, the figures given arejudged to uncertain by a factor ofthree.
In the past several studies have demon-
strated that the carcinogenic potency of
B[a]P (and other PAH) is enhanced by
adsorption to particles (34). The mecha-
nism of this effect has remained obscure
and is very complex. Apart from a carcino-
genic action of the particles per se (see
below), adsorption onto particles has been
shown to increase the retention time in
lung tissue ofPAH such as B[a]P, partlyby
decreasing the rate of metabolism (35).
This depot effect may lead to increased
induction of PAH-metabolizing enzymes,
as shown with respect to the formation of
B[a]P 7,8- and 9,10-dihydrodiols in exper-
iments with perfused lung (35,36) and
raised levels of DNA-adducts of B[a]P
metabolites, particularly the mutagenic
7,8-diol-9,10-epoxide, provided the des-
orption is not too slow (37). These
enzyme inductions result in raised doses of
genotoxic factors and may be seen as cocar-
cinogenic effects of an interaction with the
Ah receptor. A number of facts further
indicate that the promoter action of car-
cinogenic PAHs, which is also correlated
with the receptor affinity (38), is exerted
by the unmetabolized hydrocarbons rather
than by genotoxic metabolites (39). The
prolonged retention in lung tissue due to
adsorption onto particles therefore may be
seen as an increase of the promoter dose.
Because a soot core with such adsorbing
properties is not at hand in coke oven
emission to what extent these effects can be
allowed for in risk estimation by the com-
parative potency method with lung cancer
incidence in coke oven workers as reference
standard has to be clarified (22,23).
A role of the particulate material in the
development oflung tumors has been sus-
pected (40), and Pott et al. (41) have
demonstrated that the particles such as soot
play a predominant role in the development
of lung cancer in rats exposed to diesel
exhausts. This finding is supported by the
demonstration that PAH-free particles of
various kinds (carbon black, quartz, titanium
dioxide, etc.) are effective inducers oflung
cancer in the rat (41,42). The organic mate-
rial adsorbed on the particles is judged to
contribute byno more than 1% to theeffect.
Applying the multihit model of EPA
(17) to the experimental data for lung can-
cer in rats caused by diesel exhaust expo-
sure, Pott arrives at a lifetime risk of 7 x
10 5 per pg/m3 particles (41). Because
the average, airborne, diesel particle con-
tent in Sweden amounts to about 1 jig/m3
(Table 3), the risk of 7 x 10 5, or about
eight cases per year in Sweden should be
added to the value estimated from the
B[a]P content in the air, which concerns
mainly B[a]P from other sources, particu-
larlygasoline exhausts (Table 4).
It is satisfactory, as a basis for preventive
measures, that the carcinogenic action ofpar-
ticles has been demonstrated according to the
above information and that a risk estimate
has been provided for this factor. A number
exposed playa minor role; this was shown for
theepoxidedoses from alkenes (45).
It is important to characterize the induc-
tion status of humans with respect to
metabolism ofPAH. It has been proposed
that urban air may be polluted sufficiently
to induce PAH metabolism (46), a putative
mechanism of synergisms with xenobiotics
from other sources. The risk estimate
appears to be low, however, as compared to
indications from epidemiological studies
(which, it should be stressed, are also unable
to exclude a threshold) (1). Consider, for
example, the studies of Garshick et al.
(47,48) ofAmerican railroad workers, the
most extensive diesel-epidemiological study
ever carried out. Disregarding that smok-
ing data are incomplete, this study gener-
ates, according to evaluations ofMcClellan
et al. (10) based on the most likely expo-
sure level, 125 pg/mi particles (49,50) and
at 500 pg/m3, a higher but possible level,
the lifetime risk figures are 120 x 10O5 and
30 x 10 5 per pg/mi3, respectively, corre-
sponding to 150 or 40 lung cancer cases
annually, respectively. These figures are
about 10 times higher than those extrapo-
lated from animal data (Table 4). Ifdose-
response curves are linear in the low-dose
range and if life-time doses are considered
in the extrapolation, higher risk values
would be obtained.
It should be realized that in studies lim-
ited to the particles or extracts from parti-
cles, contributions from volatile and semi-
volatile components are not recognized. As
mentioned above, Barfknecht et al. (30)
showed that fluoranthene, a quantitatively
major component occurring in concentra-
tions much higher than that ofB[a]P, is an
effective mutagen and contributes to 30%
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ofthe mutagenicity in human cells ofPAH
from diesel particles. In contrast to B[a]P,
the more volatile fluoranthene occurs partly
in the gas phase (Table 2). Despite its high
mutagenic effectiveness, confirmed byVaca
et al. (39), the carcinogenic potency offlu-
oranthene tested alone is about 100 times
lower than that ofB[a]P (51), exceptwhen
administered together with B[a]P (52).
For the proper risk estimation of ambient
PAH, it appears that a key problem is clari-
fying the relevance of experiments with
mice to risk in man, particularly by mea-
surement of target doses through levels of
macromolecule adducts.
OtherSites; UptakeviatheFood
The previously mentioned preliminary risk
estimate, where B[a]P was used as indicator
led to approximately 65 cases per year in
Sweden from particle-bound organic mate-
rial (27). From a study of the origin of
PAH in food (53), it was judged that not
more than about 1/5 could be formed dur-
ing food preparation such as grilling and
that the remaining 4/5 might originate
from precipitated particulate material. The
dose from this intake was estimated to be
five times larger than the dose received
through inhalation. The collective risk in
Sweden from this source was given as 300
cases per year (Table 4) (27). In other
studies it has been confirmed that the
dietary intake ofPAH is large compared to
the uptake via inhalation (54,55).
However, the data for the uptake of PAH
(or POM) via the food chain and for the
origin ofthis material are limited.
Basic data for the dose distribution in
the body following uptake ofPAH or indi-
vidual indicators via the respiratory tract
and/or the gastrointestinal tract are still
very incomplete. In epidemiological studies,
exposure to motor exhausts has been asso-
ciated with a raised incidence of tumors
other than lung cancer, mainly bladder
cancer (possibly with nitroarenes in diesel
exhausts as a causative factor) and multiple
myeloma (56). Chimney sweeps exhibit a
raised incidence of cancer of several types,
with inhaled PAH being assumed to be a
main etiological factor (57). For these rea-
sons the previous values for systemic
tumors and for tumors due to food uptake
are retained, noting that the estimates are
very rough and of an order of magnitude
that calls for better characterization.
Benzene
Leukemia
Occupational exposure to benzene has
been shown to accompany an increased risk
primarily of acute myeloic leukemia.
Applying the unit risk coefficient of the
EPA (15), 8 x 10 6 (pg/m3)-1, to the cal-
culated average exposure level, 3.6 pg/m3,
generates a lifetime leukemia risk of 3 x
10 , orabout five cases annually in Sweden.
Earlier risk assessments of benzene have
been reviewed by Bailer and Hoel (58).
Reevaluation of data upon which the
risk estimates have been based has indicat-
ed that the assessed risks might be too high.
The exposure assessment has met difficul-
ties, and the linearity of the dose-response
relationship for leukemia has been ques-
tioned by Lamm et al. (59) and the Health
Council of the Netherlands (60). By
applying a multiplicative model, the latter
arrives at a risk that is about 4 times lower
than the EPA estimate (15), but considers
that the true risk at ppb concentrations (1
ppb = 3.1 pg/m3) may be 100 times lower
than that estimated by the EPA in 1984
(which is similar to that of 1990). The
evaluation ofBrett et al. (61) indicates the
leukemia risk to be some three times lower
than the one assumed above. Medinsky
points out that risk per unit dose may be
higher at low levels because ofsaturation of
metabolism at the high doses where effects
have been observed (62).
Other Forms ofCancer
The genotoxic effect from benzene has
been enigmatic. It has been difficult to
produce mutations in in vitro test systems
(63, unpublished data from this laborato-
ry), and DNA and hemoglobin adducts
have been observed only recently (64,65).
One reason for these difficulties may be
that genotoxic metabolites are bound pre-
dominantly to S9 proteins in the test medi-
um because ofhigh reactivity, as seen when
radiolabeled benzene is used (unpublished
data). An important contribution to the
solution of the problem is the systematic
genotoxicity testing of various benzene
metabolites carried out by Glatt et al. (66).
In Salmonella typhimurium strain TA1535
only trans-1,2-dihydrodiol and the diol-
epoxides proved mutagenic. A surprising
effect was the strong mutagenic response to
quinone and hydroquinone (and to com-
pounds that can give rise to quinones to a
lesser extent) in tests for induction of 6-
thioguanine resistance in V79 cells (66).
These compounds, in contrast to the alky-
lating diol-epoxides, were inactive for the
induction ofouabaine resistance (i.e., point
mutation). They may act by a mechanism
related to the chromosome fragmentation
(67,68) to be caused by a range of com-
pounds that can be oxidized to o- or p-
quinones which could lead to deletions.
Hydroquinone and other benzene metabo-
lites also have been shown to cause geno-
toxic effects in vivo (69,70).
Cancer tests in the last few years have
shown increased incidence of cancer in
numerous organs (71-73), which is in
accordance with the test substance giving
an initiator dose in the entire body. In
humans an increased incidence of lym-
phoma has been shown (74), and in a
comprehensive Chinese cohort study, a
raised incidence of tumors at several sites,
including lung, liver, and colon, was shown
(75). In view ofthis it is reasonable to pre-
sume that the total cancer risk is at least
three times higher than the leukemia risk.
(In the cited Chinese study this ratio was
about 10 in males.)
Carbonyl Compounds
Though also formed in larger amounts by
the use of methanol or ethanol as engine
fuel, quantitatively important air pollutants
are low molecular weight aldehydes such as
formaldehyde and acetaldehyde, generally
formed during combustion oforganic mat-
ter. Also formed from methanol and
ethanol fuels, a,P-unsaturated carbonyl
compounds are distinguished for having
veryhigh cell toxicity. Double bond epoxi-
dation may lead to more efficiently muta-
genic compounds. Because ofthe carbonyl
group's reactivity, these epoxides are cross-
linking and, therefore, highly genotoxic.
Formaldehyde
The lifetime cancer risk estimated by
applying the EPA unit risk factor, 1 x 10-5
per pg/m3, to the average exposure level in
Sweden, 1.2 pig/m3, would be 1.2 x 10-5
corresponding to two cases ofnaso-pharyn-
geal cancer annually.
Formaldehyde is clearly genotoxic in a
large number of test systems (76,77). It
has been shown to reactwith DNA in differ-
ent ways, with base changes as well as cross-
linkages between DNA and proteins as a
consequence (78). Formaldehyde can also act
as a co-mutagen (cocarcinogen) by obstruct-
ing repair ofDNA damage (79). From such
data one can expect that formaldehyde acts as
an initiator in many organs. One complica-
tion in risk assessment is that the substance is
a normal metabolite, although it may be
assumed through compartmentalization to be
held separate from the cells' DNA. It should
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also be realized that relatively high indoor
concentrations ofcarbonyl compounds, par-
ticularly formaldehyde, are created by emis-
sion frombuildingmaterials andthelike.
Cancer tests with rodents exposed to
formaldehyde in the air show tumors limited
exdusively to the nasal membranes (80,81).
The dose-response relationship for this effect
is markedly convex, a possible consequence
of irritation or cell damage leading to pro-
moter action. From only these animal data,
it is impossible to determine whether a zero-
effect threshold exists or not.
The rat and the mouse breathe only
through the nose, unlike to humans. If
animal experiments have any relevance to
human risk, it would seem possible that
formaldehyde exposure could lead to risk
of cancer in the nose, pharynx, larynx, and
lungs. Epidemiological investigations have
been negative for the most part and have led
to the assessment (concerning naso-pharynx
cancer) that humans are less sensitive to
formaldehyde than rats (82). A large study
published by the National Cancer Institute
(NCI) (83) also produced negative results, but
it suggested a synergism between formalde-
hyde and partides. This study has been criti-
cized (84). Analyzing the Swedish Cancer-
Environment Registry and using total cancer
incidence to allow for the healthy-worker
effect, Ehrenberg et al. (85) found a weakly
significant (p<0.05), approximately 30%
increase of nose and larynx cancer incidence
in occupational groups with exposure to
formaldehyde (in all approximately 10,000
persons wereexamined during 1961-1967).
A reevaluation of the above-mentioned
NCI study with regard to "the healthy-
worker effect" neglected in the original
study shows a significant increase of lung
cancer risk as well as the total cancer risk
(86). With an exposure dose of 1 ppm per
year, the relative risk is measured at
approximately 1.7 for lung cancer and
approximately 1.5 for all cancer forms.
Assuming linear dose-risk relationships and
applying these figures to the estimated
average exposure level, 1.2 ppb, the annual
number of lung cancer cases (3000), and
total cancer cases (40,000), the following
numbers ofcases in Sweden are obtained:
lung cancer is:
1.2x 10 x0.7x3000""3cases/year
and all cancers are:
1.2 x 103 x 0.5 x40,000 25 cases/year.
For several reasons, the risk estimated by
application of the unit risk factor based on
animal experiments should be considered
very uncertain and might very well overesti-
mate the risk of naso-pharynx cancer (87).
We find it appropriate to use a figure for all
cancer, despite all uncertainties, ofabout 25
cases annually in Sweden. Either choice
might be used for regulatory purposes, ifit is
realized that furtherwork is required to deter-
mine a value ofthe true risk. In such work,
improved understanding of the mechanism
of action and, ifpossible, in vivo dosimetry
will playan important role (88,89).
Acetaldehyde
Acetaldehyde is apparently genotoxic among
other things, due to its cross-linking ability.
According to animal experiments (90),
acetaldehyde is cancer-producing in the upper
airways, with both initiator and promoter
activity. The lifetime cancer riskestimated by
applying the unit risk factor, 2 x 10 6, to the
average exposure level in Sweden, aypproxi-
mately 1 lsg/m , would be 2 x 10 , corre-
sponding to 0.2 cases annually in Sweden.
This figure is very uncertain but can be taken
to indicate that at present exposure levels
(which might changewith the introduction of
ethanol-basedfuels) the risk is small.
Alkenes
Ethene
In thejudgment ofIARC ethene is referred to
group 3, meaning that "the agent is not classi-
fiable as to its carcinogenicity to humans"
(56). The background ofthis categorization
is an interesting epistemological question.
Ethene has been shown beyond doubt to be
metabolized in animals (45,91-93) and in
humans (20,94-96) to an established animal
and probable human carcinogen, ethylene
oxide. However, the metabolism is saturable,
and the highest concentration of ethylene
oxide that can be reached in the tissues corre-
sponds to the one established during exposure
to approximately 5 ppm ethylene oxide. In
long-term animal tests, a concentration
between 10 and 30 ppm is required for
obtaining sufficient power to detect the raised
incidence at, for instance, 5% significance
level in agroupof100 animals (97).
The weighted average concentration to
which the Swedish population is exposed is
set at 1.8 pg/mi3 (Table 1). Counting with
5% of the inhaled amount being metabo-
lized to ethylene oxide (94,98), the lifetime
cancer risk estimated by applying the4unit
risk factor for ethylene oxide, 1 x 10 per
pg/m , to the average exposure level of
ethene in Sweden would be 1.4 x 10-5, cor-
responding to two cases annually.
The absorbed amount corresponds to
(0.05 x 20 m3/day) x (1.8 x 1010-3
mg/m3) x 365 (day/year) = 0.657 mg/year
being metabolized annually, with an annu-
al ethylene oxide dose of
0.657 mg/year
70(kg bw) x 28(mg/mmole) x 3(h-')
1.12x10 4mMh/year [7]
where 3h-I is the adopted rate ofelimination
ofethylene oxide in humans. Using the rad-
equivalence for acute doses of 80 rad-equiva-
lents per mMh, the annual rad-equivalent
dose is estimated to 9 x 10-3 rad-equivalents
per year. Considering that the risk may be
about four times lower at low dose rate
(8,94), the riskwould be 125 x 10 6 in alife-
time or 1.8 x 10 6 per year. In the Swedish
population this would correspond to 15
deaths annually. The number ofdiagnosed
cases in Sweden would be about two times
larger, or about 30 cases annually. This esti-
mate is higher than the one based on the unit
riskfactorofEPAbyabout one orderofmag-
nitude. However, it shows certain agreement
with observed incidence of leukemias and
cancer in blood and lymphatic organs in work
environments considering thattheincidenceof
leukemias amounts to about one-tenth ofthe
total cancer incidence. The absence of epi-
demiological dataforothercancers maybedue
to theshortobservationperiods.
In densely populated and trafficked areas
the risk of cancer death may be on the
order of 2 x 10-5/year due to higher con-
centration of ethene. It must be stressed
that the given estimate for ethene has a
great uncertainty, due to other uncertain-
ties with respect to average exposure con-
centration, fraction ofinhaled amount that
is metabolized to ethylene oxide, and the
true value of the rad-equivalent at current
dose rates. In addition there is consider-
able theoretical uncertainty regarding the
extrapolation models used. The overall
uncertainty has been judged to amount to
at least a factor ofthree (96).
Propene
The weighted average concentration to
which the Swedish population is exposed
to propene is estimated to 2.3 pg/m3
(Table 1). As with ethene, it is estimated
from animal experiments that approximate-
ly 5% ofinhaled propene is metabolized to
propylene oxide (99). This compound
appears to be detoxified 4 times faster than
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ethylene oxide in animals exposed to
engine exhausts (45) to 20 times faster
than ethylene oxide in smokers (98). The
two epoxides are equally effective point
mutagens, though ethylene oxide is more
effective than propylene oxide with respect
to genetic effects involving recombination
(100). In this situation, it appears prudent
to assume the risk from propylene oxide to
be five times less than the risk from ethyl-
ene oxide. With the rad-equivalence
approach we would expect a lifetime risk of
2 x 10 , corresponding to some five cases
annually.
Butadiene
The lifetime cancer risk estimated by
applying the unit risk factor, 3 x 10 4, to
the average ambient level in Sweden, 0.7
pg/m , would be 2.1 x 10 , correspond-
ing to 25 cases annually. As judged from
animal assays butadiene exhibits a consider-
ably higher risk than ethene (more than
one order ofmagnitude) at equal exposure
doses or equal amounts retained in the
body. This difference becomes even larger
if, as expected from preliminary measure-
ments (unpublished material), the primary
metabolite vinyloxirane is detoxified faster
than ethylene oxide. From available data
(including a cancer test), it is expected that
ethylene oxide and vinyloxirane are approx-
imately equally effective mutagens or can-
cer initiators, and the high potency of
butadiene is probably due to the further
metabolism of vinyloxirane to diepoxybu-
tane(s) (three isomers possible). R- or S-
Diepoxybutane exhibit a genotoxic potency
in several materials that is one to two
orders of magnitude greater than that of
monofunctional epoxides, an effect attrib-
uted to the ability of the diepoxide to
cross-link DNA bases (primarily guanines)
in the same DNA strand or in the comple-
mentary strands (101). This higher poten-
cy of diepoxybutane also is compatible
with results ofcancer tests. Aldehydes such
as 2-butenedial also may contribute to
bone marrow damage in the same manner
as muconaldehyde (102,103). Dahl et al.
(104,105) have demonstrated species dif-
ferences in metabolism of reactive com-
pounds, the blood concentration of toxic
metabolites and of hemoglobin adducts
being lower in monkeys than in rats or
mice. For that reason risk estimation from
animal tests should be based on the doses
of essential metabolites measured in both
animal models and humans. For these rea-
sons criticism of risk estimation ofbutadi-
ene from experimental data is well-founded,
particularly since comparison with epi-
demiological data indicate that such extrap-
olation leads to erroneous values (106).
Conclusion
The cancer risks estimated by the lifetime
unit risk approach and the risks judged to be
more realistic are summarized in Table 4.
Due to the incompleteness ofthe list ofcom-
pounds considered and with regard to the
uncertainties ofthe estimates, it is appropri-
ate not to compute atotal riskbysummation
of the risks for the individual components.
Adding to the uncertainty is the fact that
outdoor levels have been considered valid for
the indoor situation as well. It appears pru-
dent to consider the adopted estimates in
Table 4 to be uncertain byafactorofthree.
The deviations ofadopted risks from the
risks estimated by using unit risk factors can-
not be taken to reflect an availability ofstrong
data that prove the incorrectness ofthe latter.
Rather, they are a reflection ofideas about the
background ofuncertainties and ways to solve
theproblems. Majorcauses ofthese deviations
are thepresendyhypothetical expectations that
the riskis afunction ofthelifetime accumulat-
ed dose rather than ofthe dose per day and
that initiators which deliver a dose all over the
body will, as with ionizing radiation, cause
cancer in most organs. The latter is indicated
to be the case in both humans and animals for
PAH, formaldehyde, andbenzene. Forethene
and ethylene oxide, however, the animal test
datahavestill nocounterpart indication in epi-
demiological observations of excess solid
tumors; the observed stomach tumors have
occurred ataproduction plantwithsimultane-
ous exposure to other chemicals (20,107,
unpublished material). Areliable riskestimate
for urban air pollution cannot be made with-
out integration of data sets for exposed
humans, laboratory animals, and cells com-
bined with improved understanding ofaction
mechanisms ofrelevance at low exposure lev-
els. AsexpressedbyMcClellan etal., this
is a formidable challenge especially for esti-
mating risks at levels likely to be encoun-
tered in the general environment. Because
of the substantial data that already exists on
diesel exhausts, it is an attractive model for
further studies (10).
It is our belief that measurement of target
doses will be essential in the solution of
these problems.
The present risks estimated forcertain com-
ponents (e.g., ethene) are lower as compared
to earlier estimates (4,27,94). This is due
mainly to a change in the pollution level, the
earlier estimates using figures valid a decade
ago, and the present figures considering the
cases induced attoday's levels.
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